Perpetua Medical AB (publ)

PERP-B · Nasdaq Stockholm · Healthcare

2.32SEK −3.3%last day

Price as of 1 October 2026

The price over the past year, with dividends: −48.6%

Performance

1 month

−14.7%

1 year

−48.6%

3 years, per year

−15.5%

5 years, per year

−57.9%

Largest fall, 3 years

−99.7%

Below the peak now

−99.6%

Volatility, 1 year

82.6%

Return with dividends reinvested.

Key figures

P/E

56.5

P/B

1.2

Dividend yield

0.0%

Return on equity

+2.1%

Net margin

+1.7%

Market value

2 m USD

Quality, value and trend

Where Perpetua Medical stands against every Nordic stock today. 100 is best.

Quality13

Profitability and a sound balance sheet over time. Better than 13% of Nordic stocks.

Value64

The price measured against earnings, assets and cash flow. Better than 64% of Nordic stocks.

Trend6

The price development over the past year. Better than 6% of Nordic stocks.

Combined11

Quality, value and trend together. Better than 11% of Nordic stocks.

About Perpetua Medical

Perpetua Medical AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 12 employees.

Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024. Perpetua Medical AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis